Aurobindo Pharma rises on getting USFDA’s approval for Rizatriptan Benzoate Tablets

02 Jul 2013 Evaluate

Aurobindo Pharma is currently trading at Rs. 187.75, up by 0.85 points or 0.45% from its previous closing of Rs. 186.90 on the BSE.

The scrip opened at Rs. 187.95 and has touched a high and low of Rs. 189.90 and Rs. 185.00 respectively. So far 148122 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 204.90 on 07-Jan-2013 and a 52 week low of Rs. 99.65 on 10-Aug-2012.

Last one week high and low of the scrip stood at Rs. 189.90 and Rs. 151.15 respectively. The current market cap of the company is Rs. 5404.88 crore.

The promoters holding in the company stood at 54.84% while Institutions and Non-Institutions held 31.87% and 13.29% respectively.

Aurobindo Pharma has received final approvals from the US Food & Drug Administration (USFDA) to manufacture and market Rizatriptan Benzoate Orally Disintegrating Tablets (ODT) 5mg and 10mg. The Abbreviated New Drug Application (ANDA) 203062 is ready for launch.

Rizatriptan Benzoate ODT 5mg and 10mg are the generic equivalent of Merck & Co. Inc’s Maxalt-MLT ODT 5mg and 10mg respectively and indicated for the acute treatment of migraine in adults and in pediatric patients 6 to 17 years of age.

The annual sale of the product is about $271 million for 12 months ending April 2013 as per IMS. The product has been approved out of Unit VII (SEZ) formulations facility in Hyderabad, India.

The company, now has a total of 192 ANDA approvals (164 Final approvals including 4 from Aurolife Pharma LLC and 28 Tentative approvals) from USFDA.

Aurobindo Pharma Share Price

1185.50 -8.20 (-0.69%)
15-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1797.25
Dr. Reddys Lab 1280.40
Cipla 1507.25
Zydus Lifesciences 921.25
Lupin 2090.15
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×